Skip to content
healthcare.dev

Enoxaparin Sodium

NDC 63323-537, enoxaparin sodium, injection, from Fresenius Kabi USA, LLC.

Product NDC
63323-537
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA020164
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-537 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENOXAPARIN SODIUM150 mg/mL

Pharmacologic classes

Heparin, Low-Molecular-Weight [CS]; Low Molecular Weight Heparin [EPC]

Package NDCNDC-11Package
63323-537-846332305378410 CELLO PACK in 1 CARTON (63323-537-84) / 1 SYRINGE in 1 CELLO PACK (63323-537-01) / 1 mL in 1 SYRINGE
63323-537-946332305379410 CELLO PACK in 1 CARTON (63323-537-94) / 1 SYRINGE in 1 CELLO PACK (63323-537-04) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=63323-537

Use it

Look up 63323-537 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-537 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-537. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.